Artelo Biosciences, Inc.
General ticker "ARTL" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.6M (TTM average)
Artelo Biosciences, Inc. does not follow the US Stock Market performance with the rate: -2.6%.
Estimated limits based on current volatility of 6.0%: low 1.64$, high 1.95$
Factors to consider:
- Total employees count: 6 (0.0%) as of 2024
- Top business risk factors: Operational and conduct risks, Capital raising, Liquidity and credit risks, Geopolitical risks, Trade policy changes
- Current price 44.9% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.74$, 10.43$]
- 2025-12-31 to 2026-12-31 estimated range: [2.75$, 7.98$]
Financial Metrics affecting the ARTL estimates:
- Negative: with PPE of -0.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -43.16 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Positive: 41.86 < Shareholder equity ratio, % of 60.81 <= 63.39
- Positive: Investing cash flow per share per price, % of 40.15 > -0.66
- Negative: Industry earnings per price (median), % of -16.34 <= 0
- Negative: negative Industry operating cash flow (median)
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term ARTL quotes
Long-term ARTL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $10.29MM | $9.93MM | $10.11MM |
| Operating Income | $-10.29MM | $-9.93MM | $-10.11MM |
| Non-Operating Income | $0.20MM | $0.64MM | $0.28MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| R&D Expense | $4.32MM | $5.70MM | $5.99MM |
| Income(Loss) | $-10.08MM | $-9.29MM | $-9.83MM |
| Profit(Loss)* | $-10.08MM | $-9.29MM | $-9.83MM |
| Stockholders Equity | $19.40MM | $11.75MM | $2.86MM |
| Assets | $20.42MM | $13.04MM | $4.70MM |
| Operating Cash Flow | $-8.01MM | $-8.21MM | $-8.35MM |
| Investing Cash Flow | $2.96MM | $3.51MM | $7.77MM |
| Financing Cash Flow | $0.00MM | $0.57MM | $0.11MM |
| Earnings Per Share** | $-21.36 | $-3.14 | $-3.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.